These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9232946)

  • 21. Plasmapheresis in neuroleptic malignant syndrome.
    Gaitini L; Fradis M; Vaida S; Krimerman S; Beny A
    Anaesthesia; 1997 Feb; 52(2):165-8. PubMed ID: 9059103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel antipsychotics and neuroleptic malignant syndrome.
    Buckley P
    Psychiatr Serv; 1996 Apr; 47(4):431. PubMed ID: 8689381
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
    Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
    Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome without fever: a report of three cases.
    Peiris DT; Kuruppuarachchi K; Weerasena LP; Seneviratne SL; Tilakaratna YT; De Silva HJ; Wijesiriwardena B
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):277-8. PubMed ID: 10960291
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neuroleptic malignant syndrome in users of risperidone].
    van Waarde JA; Kuiper J; Verwey B
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychiatric Emergencies for Clinicians: Emergency Department Management of Neuroleptic Malignant Syndrome.
    Wilson MP; Vilke GM; Hayden SR; Nordstrom K
    J Emerg Med; 2016 Jul; 51(1):66-9. PubMed ID: 27247083
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neuroleptic malignant syndrome].
    Dahm JB; Trenckmann U
    Med Klin (Munich); 1991 Nov; 86(11):601-4. PubMed ID: 1685215
    [No Abstract]   [Full Text] [Related]  

  • 30. Partially Treated Catatonia and Incipient Neuroleptic Malignant Syndrome: A Challenging Presentation.
    Mahgoub Y; Uy R; Hartman J
    Prim Care Companion CNS Disord; 2020 Oct; 22(5):. PubMed ID: 33031648
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome associated with acute organophosphate poisoning: Case report.
    Angulo NY; Castaño PA; Gómez CC; Quintero S
    Biomedica; 2022 Sep; 42(3):445-449. PubMed ID: 36122284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium-induced fatal neuroleptic malignant syndrome in a patient not being concomitantly treated with commonly offending agents.
    Argyriou AA; Drakoulogona O; Karanasios P; Kouliasa L; Leonidou L; Giannakopoulou F; Goudas P; Makris N
    J Pain Symptom Manage; 2012 Dec; 44(6):e4-6. PubMed ID: 23217454
    [No Abstract]   [Full Text] [Related]  

  • 33. Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.
    Brantley E; Cohn J; Babu K
    J Med Toxicol; 2009 Jun; 5(2):92-8. PubMed ID: 19415596
    [No Abstract]   [Full Text] [Related]  

  • 34. An agitated young man.
    Mann F; Sobel A
    BMJ; 2010 Mar; 340():c732. PubMed ID: 20356963
    [No Abstract]   [Full Text] [Related]  

  • 35. Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment.
    Oglodek E; Szota A; Araszkiewicz A
    Aust N Z J Psychiatry; 2013 Oct; 47(10):972. PubMed ID: 23630396
    [No Abstract]   [Full Text] [Related]  

  • 36. Recognition, assessment and management of neuroleptic malignant syndrome.
    Khan M; Farver D
    S D J Med; 2000 Sep; 53(9):395-400. PubMed ID: 11016275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome and its controversies.
    Margetić B; Aukst-Margetić B
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome: review and analysis of 115 cases.
    Addonizio G; Susman VL; Roth SD
    Biol Psychiatry; 1987 Aug; 22(8):1004-20. PubMed ID: 2886157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Neuroleptic Malignant Syndrome].
    Nagel M; Freisberg S; Junghanns K; Moll CK; Willenborg B
    Fortschr Neurol Psychiatr; 2015 Jul; 83(7):373-80. PubMed ID: 26200042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of nonneuroleptic malignant syndrome.
    Cohen S; Fligner CL; Raisys VA; Luthi R; Dunner DL
    J Clin Psychiatry; 1987 Jul; 48(7):287-8. PubMed ID: 2885311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.